Imaging of Vulnerable Plaques Using Near-Infrared Spectroscopy for Risk Stratification of Atherosclerosis Saurabh SanonTim DaoRobert Chilton Coronary Heart Disease (JA Farmer, Section Editor) 09 January 2013 Article: 304
Pharmacologic Interactions of Multidrug Therapy for Dyslipidemia Nidhi MehtaEmil M. deGoma Nonstatin Drugs (WB Borden, Section Editor) 09 January 2013 Article: 303
Advances in Pharmacologic Therapies for Type 2 Diabetes Linde M. MorsinkMark M. SmitsMichaela Diamant Nonstatin Drugs (WB Borden, Section Editor) 09 January 2013 Article: 302
Do the Frequencies of Adverse Events Increase, Decrease, or Stay the Same with Long-Term Use of Statins? Karlyn HuddyPavittarpaul DhesiPaul D. Thompson Statin Drugs (MB Clearfield, Section Editor) 09 January 2013 Article: 301
Is the Future of Statins Aligned with New Novel Lipid Modulation Therapies? Binh An P. PhanPeter P. Toth Statin Drugs (MB Clearfield, Section Editor) 10 January 2013 Article: 300
Statins and Diabetes: The Good, the Bad, and the Unknown Kelly AxsomJeffrey S. BergerArthur Z. Schwartzbard Statin Drugs (MB Clearfield, Section Editor) 09 January 2013 Article: 299
The Evolution or Revolution of Statin Therapy in Primary Prevention: Where Do We Go From Here? Patricia RehfieldColin Kopes-KerrMichael Clearfield Statin Drugs (MB Clearfield, Section Editor) 09 January 2013 Article: 298
Does the Benefit from Statin Therapy Extend Beyond 5 Years? Richard BulbuliaJane Armitage Statin Drugs (MB Clearfield, Section Editor) 09 January 2013 Article: 297